Sector News

Vertellus Acquires Pentagon Chemicals

November 3, 2014
Energy & Chemical Value Chain
Vertellus, the world’s leading producer of pyridine and pyridine derivative chemicals, today announced that it has purchased Pentagon Chemicals, a leading manufacturer of fine and specialty chemicals used in the life sciences industry. The acquisition significantly expands Vertellus’ manufacturing presence in the agrochemical and pharmaceutical sectors and positions Vertellus to complement its current chemistries with U.K.-based Pentagon’s strong capabilities in phosgenation, chlorination and sodium dispersion, among others.
 
The transaction is expected to boost earnings of Vertellus Specialty Materials division approximately 20 percent, contributing to an approximate 13 percent increase in total company revenue. The acquisition of Pentagon is part of Vertellus’ vision to expand its Specialty Materials footprint in the life science sector through both organic growth and strategic acquisitions. Revenues from life science applications represent more than 65 percent of the company’s total revenue, and Vertellus expects the acquisition will significantly increase its agriculture chemical and pharmaceutical business.
 
According to Vertellus CEO Rich Preziotti, the company was impressed with Pentagon’s expertise in producing high value reagents used to produce complex molecules and Pentagon’s market leadership as a supplier of maleic anhydride derivatives that complement Vertellus’ ASA business. He added that the complementary chemical expertise between the two businesses also aligns with their manufacturing locations. “Beyond the chemistry fit, Pentagon operates two high quality U.K. manufacturing sites which build upon Vertellus’ position in the northern U.K. Having three sites in close proximity to each other will enable us to build a robust infrastructure to support additional growth,” Preziotti said.
 
Integration of the two business units is underway and company leaders will publicly introduce the partnership during the Chemical Industries Association annual dinner in London, on November 20. “Given the complementary capabilities of Vertellus and Pentagon, we look forward to supplying life science companies with a high quality supply of critical intermediates delivered by a team who understands both the complex chemistries and the business markets in which they are used,” Preziotti said.
 
Source: Vertellus

comments closed

Related News

March 24, 2024

Thomas Gangl leaves Borealis

Energy & Chemical Value Chain

Appointed Borealis CEO in 2021, Thomas has led key initiatives including the sale of the nitrogen business, acquisitions of Rialti Spa and Integra Plastics AD, and Borouge’s IPO. He also made the final investment decision for the Borouge 4 plant, set to be the world’s largest polyolefin complex.

March 24, 2024

Chemours names Dignam permanent CEO

Energy & Chemical Value Chain

The Chemours Co. today named interim CEO Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately. Dignam has been interim CEO since late February, when former CEO Mark Newman was placed on leave due to an internal investigation.

March 24, 2024

Neste merges three business lines into new Renewable Products unit

Energy & Chemical Value Chain

Neste Corp. (Espoo, Finland) has completed its organizational change process, announced on 1 November 2023. Neste informed that it will merge its three renewable business units into one Renewable Products business unit as well as restructure its functions to better support business-driven ways of working.

How can we help you?

We're easy to reach